Clinical Trials
2 trialsNCT06047535 2023-09-21
Naxitamab and Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF) Combined With Isotretinoin for Maintenance Treatment of Patients With High-Risk Neuroblastoma in First Complete Response.
SciClone Pharmaceuticals
Phase 4 Not yet recruiting
NCT05918432 2023-06-26
Determining Patterns In Study Experiences of Neuroblastoma Patients
Power Life Sciences Inc.
Not yet recruiting